{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"BioCardia, Inc."},"Symbol":{"label":"Symbol","value":"BCDA"},"Address":{"label":"Address","value":"320 SOQUEL WAY,SUITE B, SUNNYVALE, California, 94085, United States"},"Phone":{"label":"Phone","value":"+1 650 226-0120"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack."},"CompanyUrl":{"label":"Company Url","value":"https://www.biocardia.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Debby Holmes-Higgin","title":"Vice President-Clinical"},{"name":"Ian McNiece","title":"Chief Scientific Officer"},{"name":"Peter Alan Altman","title":"President, Chief Executive Officer & Director"},{"name":"Sujith Shetty","title":"Chief Medical Officer, VP-Clinical & Regulatory"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}